| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 442.32B | 460.51B | 441.71B | 409.20B | 349.96B |
| Gross Profit | 54.44B | 62.97B | 59.85B | 53.41B | 54.24B |
| EBITDA | 24.68B | 35.10B | 35.08B | 30.70B | 36.99B |
| Net Income | 7.13B | 8.63B | 10.21B | 5.34B | 12.42B |
Balance Sheet | |||||
| Total Assets | 422.71B | 432.37B | 446.21B | 416.23B | 415.99B |
| Cash, Cash Equivalents and Short-Term Investments | 92.60B | 111.54B | 150.75B | 132.91B | 139.59B |
| Total Debt | 0.00 | 5.76B | 4.66B | 4.82B | 6.03B |
| Total Liabilities | 95.11B | 106.68B | 97.51B | 92.77B | 90.40B |
| Stockholders Equity | 309.87B | 306.30B | 326.93B | 298.79B | 296.86B |
Cash Flow | |||||
| Free Cash Flow | 3.36B | 11.72B | 24.60B | 17.01B | 6.24B |
| Operating Cash Flow | 22.61B | 28.71B | 37.66B | 30.45B | 20.02B |
| Investing Cash Flow | -23.72B | -35.87B | -8.73B | -20.52B | -16.57B |
| Financing Cash Flow | -22.72B | -31.44B | -17.75B | -19.31B | -24.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥75.32B | 7.48 | 11.87% | 5.00% | -5.74% | -17.86% | |
78 Outperform | ¥676.40B | 17.63 | ― | 2.60% | 1.89% | -39.75% | |
74 Outperform | ¥543.49B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
68 Neutral | ¥210.15B | 21.03 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥400.87B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% | |
60 Neutral | ¥1.79T | 6.16 | 8.34% | 2.03% | 4.53% | 65.12% |